600 seniors join quest to unlock Alzheimer's earliest secrets

NCT ID NCT06953167

Recruiting now Knowledge-focused Sponsor: Imperial College London Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 600 volunteers aged 65 and older over several years to track changes in memory, thinking, and biological markers like amyloid proteins. Researchers hope to identify early warning signs of Alzheimer's disease before obvious symptoms appear. The goal is to improve early detection and pave the way for future prevention strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify early signs of Alzheimer's, leading to earlier diagnosis and better prevention strategies in the future.
What could go wrong: This is an observational study, not a treatment trial. It may not directly lead to new therapies, and results may take years to translate into clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE (AD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Cognitive Dysfunction dementia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALZHEIMER'S DISEASE (AD)

Contacts and locations

Locations

Imperial College London
RECRUITING

London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.